Monthly Archives: July 2017

  • IAS 2017: Closing ceremony exposes Gilead Sciences

    Conference funders, Gilead Sciences, named and shamed for its “insatiable greed” Yesterday, the 9th International AIDS Conference on HIV Science...

  • BLOG: We want dolutegravir for all, and we want it now

    Author: Othoman Mellouk, Intellectual Property and Access to Medicines Lead at the International Treatment Preparedness Coalition (ITPC). Article first published...

  • HIV activists denounce ViiV for denying 3.5 million people access to optimal treatment

    Today, Monday, 24 July 2017, during the 9th International AIDS Conference on HIV Science in Paris (IAS 2017), HIV treatment...